Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Insulin pumps lead to better clinical outcomes compared with injection

Observational study compared rates of severe hypoglycaemia in diabetes patients using insulin pump and injection therapy.

Insulin pump on young girl

Source: BSIP SA / Alamy Stock Photo

Researchers found that insulin pump therapy was associated with lower rates of severe hypoglycaemia and diabetic ketoacidosis compared with injection therapy

The use of insulin pumps in young patients with type 1 diabetes has increased substantially in the last decade, but the association with short-term diabetes complications is unclear.

Researchers carried out a population-based observational study to determine whether rates of severe hypoglycaemia and diabetic ketoacidosis were lower with insulin pump therapy compared with insulin injection therapy in children, adolescents and young adults with type 1 diabetes.

The researchers started by matching 9,814 young patients using pump therapy with 9,814 young patients using insulin therapy.

It was found that pump therapy was associated with lower rates of severe hypoglycaemia (9.55 vs 13.97 per 100 patient-years) and diabetic ketoacidosis (3.64 vs 4.26 per 100 patient years) compared with injection therapy and better glycaemic control during the most recent year of therapy.

The findings provide evidence for improved clinical outcomes associated with insulin pump therapy compared with injection therapy in young people with type 1 diabetes, the authors concluded in the Journal of the American Medical Association (10 October 2017)[1].

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203965

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.